OriGene Technologies
Stage
Loan | AliveTotal Raised
$56.12MValuation
$0000Last Raised
$1.5M | 2 yrs agoAbout OriGene Technologies
OriGene Technologies is a biosciences company dedicated to develop gene centric products and services to improve the quality of healthcare diagnostics and treatments. The Company's collection of gene based products and services are important tools to accelerate the discovery of new diagnostics and drug treatments for better patient care.
OriGene Technologies Headquarter Location
9260 Medical Center Drive Suite 4200
Rockville, Maryland, 20850,
United States
301-340-3188
Expert Collections containing OriGene Technologies
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
OriGene Technologies is included in 1 Expert Collection, including Biopharma Tech.
Biopharma Tech
838 items
Latest OriGene Technologies News
Feb 4, 2022
Dublin, IRELAND Dublin, Feb. 04, 2022 (GLOBE NEWSWIRE) -- The "Global CRISPR Market 2021-2028" report has been added to ResearchAndMarkets.com's offering. The global CRISPR market is anticipated to display growth at a CAGR of 20.38% through the projected period of 2021-2028. Factors such as growing lifestyle-oriented diseases and the surging prevalence of genetic diseases are widening the scope of the CRISPR market globally. Additionally, the advancements in gene-based therapy in the agriculture sector, coupled with the increased need for clinical trials, are opening new avenues for the global market over the forecasted period. In contrast, the rising ethical concerns relating to technology use and the absence of healthcare budgets in developing nations hamper the overall development of the CRISPR market. Regional Outlook The Asia-Pacific is estimated to observe the fastest growth in the CRISPR market over the considered phase. This growth can be attributed to the continuous research and development activities across India and China. Moreover, these countries have well-developed agriculture research facilities to develop effective and productive crops. Furthermore, the growing reliance on non-vegetarian foods, such as red meat and seafood, contributes to the market's development over the projected phase. Above all, the rising demand for aquaculture predominantly drives the growth of the CRISPR market across the APAC region. Competitive Outlook The prominent companies in the CRISPR market are Integrated DNA Technologies, Intellia therapeutics, Horizon Discovery Group, Precision Biosciences, Genscript, Novartis International AG, Editas Medicine, Caribou Biosciences Inc, Synthego Corporation, OriGene Technologies Inc, Cellectis Bioresearch SAS, CRISPR therapeutics AG, Addgene, New England Biolabs, and Lonza Group Ltd. Key Topics Covered
OriGene Technologies Web Traffic
OriGene Technologies Rank
Where is OriGene Technologies's headquarters?
OriGene Technologies's headquarters is located at 9260 Medical Center Drive, Rockville.
What is OriGene Technologies's latest funding round?
OriGene Technologies's latest funding round is Loan.
How much did OriGene Technologies raise?
OriGene Technologies raised a total of $56.12M.
Who are the investors of OriGene Technologies?
Investors of OriGene Technologies include Paycheck Protection Program, Qiming Venture Partners, IDG-Accel Capital, Cathay Capital Private Equity, Walden International and 7 more.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.